+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

V

Actively Recruiting

Researchers are conducting a validation project to assess two new questionnaires designed to measure how patients perceive the severity and control of Chronic Rhinosinusitis CRS, both with and without nasal polyps. This effort involves 32 medical centers across Europe, the USA, and South Africa, aiming to recruit a total of 1000 patients. The study seeks to validate these questionnaires in routine medical settings and compare their results with existing tools. The study involves collecting responses to the translated versions of the questionnaires from patients attending regular ear, nose, and throat ENT clinics at participating hospitals. Data collection and statistical analysis will be managed by the University of Leuvens statistical department. The questionnaires will be evaluated over an average period of six months until the studys completion. Participants will be involved by completing the questionnaires during their regular medical visits. Researchers will assess the validity and results of these questionnaires compared to other available measurement tools. The study spans approximately three years, with primary outcomes measured through patient responses and questionnaire evaluations until study completion around September 2027.

Age: 18Years +All Genders
32 locations
S

Actively Recruiting

Researchers are studying patients with splenomegaly or those who have had a splenectomy without a known cause, focusing on the possible presence of Gaucher disease GD and Acid Sphingomyelinase Deficiency ASMD. These conditions may be linked to monoclonal gammopathy of undetermined significance MGUS and multiple myeloma MM, which have been found more frequently among Gaucher and ASMD patients. The study aims to improve diagnosis of unknown causes of splenomegaly and undiagnosed cases of MGUS or MM in these patients. The study involves using standard diagnostic procedures for unknown splenomegaly and splenectomy patients, including collecting blood samples for a dry drop test DBS. This test measures enzymatic and genetic activity related to Gaucher disease and ASMD, alongside analysis of LisoGl1 and LisoSM biomarkers. No specific treatment or intervention is applied since this is an observational study. Participants will undergo clinical evaluations and blood sampling to help identify the prevalence of Gaucher disease and ASMD over a 36-month period. Researchers will track how many patients with unknown splenomegaly or MGUSMM have these enzyme deficiencies. The study is observational, with no treatment assigned, and participants will be monitored during their routine medical consultations throughout the study duration.

Age: 18Years - 99YearsAll Genders
23 locations
S

Actively Recruiting

Researchers are conducting a retrospective, observational study to create a national registry of patients diagnosed with Waldenstrms Macroglobulinemia WM and Monoclonal Gammopathy of uncertain significance -IgM MGUS-IgM in Spain over the past 30 years. WM is a B-cell lymphoproliferative disorder characterized by bone marrow infiltration and the presence of monoclonal immunoglobulin M IgM. The study aims to evaluate clinical characteristics, long-term safety and effectiveness of various treatments, and prognosis to help design future treatment strategies and clinical trials in Spain. This study collects data from patients medical records, including those who have provided informed consent and, with ethics approval, some deceased patients. Data will be compiled into a database managed by the Spanish Myeloma and Lymphoma Intergroup. The study involves adult patients diagnosed with WM or MGUS-IgM, focusing on analyzing clinical and laboratory features, treatments used, and patient outcomes over time. Participants contribute by allowing access to their clinical files for data collection. Researchers will assess overall survival over an average follow-up of four years, along with treatment responses and long-term prognosis. The study does not involve new treatments or interventions but gathers information to better understand the disease and improve future care. Participation involves no treatment changes and focuses on reviewing past and current clinical data.

Age: 18Years +All Genders
51 locations